Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1 Study of Magrolimab in Children and Adults With Recurrent or Progressive Malignant Brain Tumors

NCT05169944 is registered in ClinicalTrials.gov with University of California, San Francisco as lead sponsor.

NCT NCT05169944
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05169944 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1 Study of Magrolimab in Children and Adults With Recurrent or Progressive Malignant Brain Tumors
Lead sponsor
University of California, San Francisco
Phase
Phase 1
Overall status
Completed
Start date
April 22, 2022
Completion date
September 30, 2024
Enrollment
13 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

brain cancer, brain tumor adult, brain tumor, pediatric, malignant brain tumor, progressive malignant brain tumor, recurrent brain tumor